Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005739 |
YEM_ID: | YEM-637 |
ID: | TCMBANKHE005739/YEM-637 |
植物拉丁名: |
|
功能与主治: | To fortify spleen and disinhibit water, resolve toxin and disperse swelling./Diaphragm food, edema, sore toxin. |
药用植物名: | 蚕豆 |
药名: | 蚕豆 |
来源: | 云南民族药物志：第四卷 |
药用部位: | seed |
使用民族: | 傣族/佤族/彝族 |
TCM_ID_id: | 3692 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN002730 | d-glyceric acid | d-glycericacid | C3H6O4 | 106.08 g/mol | C(C(C(=O)O)O)O |
| TCMBANKIN004482 | wyerone acid | C14H12O4 | 244.24 g/mol | CCC=CC#CC(=O)C1=CC=C(O1)C=CC(=O)O | |
| TCMBANKIN021666 | Wyerone | 20079-30-5; methyl (2E)-3-{5-[(4Z)-hept-4-en-2-ynoyl]-2-furyl}acrylate; 3-(5-hept-4-en-2-ynoyl-furan-2-yl)-acrylic acid methyl ester; InChI=1/C15H14O4/c1-3-4-5-6-7-13(16)14-10-8-12(19-14)9-11-15(17)18-2/h4-5,8-11H,3H2,1-2H3/b5-4-,11-9; wyerone; methyl (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]furan-2-yl]prop-2-enoate; C08465; (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]-2-furyl]acrylic acid methyl ester; methyl (E)-3-[5-[(Z)-hept-4-en-2-ynoyl]-2-furyl]prop-2-enoate; (E)-3-[5-[(Z)-1-oxohept-4-en-2-ynyl]-2-furyl]prop-2-enoic acid methyl ester; 2-propenoic acid, 3-[5-[(4Z)-1-oxo-4-hepten-2-ynyl]-2-furanyl]-, methyl ester, (2E)- | C15H14O4 | 258.27 | CCC=CC#CC(=O)C1=CC=C(O1)C=CC(=O)OC |
| TCMBANKIN027920 | pipecolic acid | pipecolic acid ; pipecolicacid | C6H11NO2 | 129.16 g/mol | C1CCNC(C1)C(=O)O |
| TCMBANKIN032645 | vicine | C10H16N4O7 | 304.26 g/mol | C(C1C(C(C(C(O1)OC2=C(N=C(NC2=O)N)N)O)O)O)O | |
| TCMBANKIN032830 | vignafuran | C16H14O4 | 270.28 g/mol | COC1=CC2=C(C=C1)C=C(O2)C3=C(C=C(C=C3)O)OC | |
| TCMBANKIN050307 | d-alpha-pipecoline | d-α-pipecoline | C6H13N | 99.17 g/mol | CC1CCCCN1 |
| TCMBANKIN058156 | dopa | 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); SODIUM (2R)-1-(HYDROGEN PHOSPHONATOOXY)-3-[(9Z)-OCTADEC-9-ENOYLOXY]PROPAN-2-YL (9Z)-OCTADEC-9-ENOATE; SCHEMBL940484; 1,2-Dioleoyl-sn-glycero-3-phosphoric acid monosodium salt, >=98% (TLC); sodium (2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl hydrogen phosphate; DTXSID1039686; 116004-31-0; 1,2-dioleoyl-sn-glycero-3-phosphate (sodium salt); 18:1 PA; 1-O,2-O-Dioleoyl-L-glycerin-3-phosphoric acid sodium salt;NCGC00093869-04; Alanine, 3-(3,4-dihydroxyphenyl)-, D- (8CI); NCGC00093869-03; D-Tyrosine, 3-hydroxy- (9CI); 3-(3,4-Dihydroxyphenyl)-D-alanine; 37840_FLUKA; D-3-Hydroxytyrosine; NSC 118368; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid; (2R)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid; EINECS 227-343-0; 3-Hydroxy-D-tyrosine; D9378_SIGMA;Dopa D-form | C9H11NO4 | 197.19 g/mol | C1=CC(=C(C=C1CC(C(=O)O)N)O)O |
| TCMBANKIN058162 | LDP | nchembio801-comp8; SPBio_001205; Spectrum3_000406; 51-61-6; cMAP_000036; KBio2_006628; Spectrum5_000945; DOPAMINE; KBio3_002867; 3-Hydroxtyramine; KBio3_002962; nchembio705-8; 4-(2-Aminoethyl)benzene-1,2-diol; 3, 4-Dihydroxyphenethylamine hydrochloride; 4-(2-aminoethyl)-pyrocatechol; 62-31-7 (HYDROCHLORIDE); Pyrocatechol, 4-(2-aminoethyl)-; Intropin {[as} hydrochloride]; NSC 173182; 4-(2-Aminoethyl)-1,2-bezenediol; KBioSS_001492; EINECS 200-110-0; cMAP_000065; Lopac-H-8502; KBio2_005052; KBioSS_002393; Dophamine; KBio2_004060; HSDB 3068; L-DOPAMINE; 4-(2-Aminoethyl)pyrocatechol; KW-3-060; BSPBio_001932; AIDS156129; KBioGR_002484; NCGC00096050-02; 3,4-Dihydroxyphenylethylamine; KBio2_004956; Spectrum2_001023; NSC169105 (HYDROCHLORIDE); Spectrum4_000525; (3H)-Dopamine; KBioGR_001129; 3-Hydroxytyramine; C03758; Dopamin; KBio2_007620; Dopaminum [INN-Latin]; m-Hydroxytyramine-; BPBio1_001123; Pyrocatechol, 4-(2-aminoethyl)- (8CI); alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; KBioGR_002388; Biomol-NT_000001; 2-(3,4-dihydroxyphenyl)ethylamine; Lopac0_000586; Hydroxytyramin; DivK1c_000780; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)-1,2-benzenediol; CHEBI:18243; 3,4-dihydroxyphenethylamine; 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI); IDI1_000780; NCGC00015519-01; NSC173182; 1,2-Benzenediol, 4-(2-aminoethyl)-; 50444-17-2; Oprea1_088821; hydroxytyramine; SBB004044; NCGC00096050-01; .alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane; Spectrum_001012; Dopamine (USAN)(*hydrochloride*); KBio2_002388; KBio3_001152; nchembio.78-comp16; Oxytyramine; KBio2_001492; KBioSS_002491; KBio1_000780; AIDS-156129; KBio2_002484; NINDS_000780; NCGC00096050-04; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; Dopamina [INN-Spanish]; KBio2_007524; SPECTRUM1505155; a-(3,4-Dihydroxyphenyl)-b-aminoethane; dopamine | C8H11NO2 | 153.18 g/mol | C1=CC(=C(C=C1CCN)O)O |
| TCMBANKIN058706 | betulin | AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol | C30H50O2 | 442.7g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
| TCMBANKIN059394 | jatamansin | MolPort-003-665-745; 19427-82-8; HMS2193F07; AmbscZ-048430; BRD-K07212038-001-02-1; MLS002472947; Jatamansin; SCHEMBL12062120; [(9R)-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-h]chromen-9-yl] (Z)-2-methylbut-2-enoate; Selinidin; SPECTRUM1504159; CHEMBL457257; ZINC28040; Xanthogalin; SDCCGMLS-0066791.P001; AC1LDJE7; BDBM50069685; SMR001397055; BSPBio_003337; J3.496.931K; Spectrum5_000398; (Z)-2-Methyl-2-butenoic acid (9R)-8,8-dimethyl-2-oxo-9,10-dihydro-2H,8H-benzo[1,2-b:3,4-b']dipyran-9-yl ester | C19H20O5 | 328.4 g/mol | CC=C(C)C(=O)OC1CC2=C(C=CC3=C2OC(=O)C=C3)OC1(C)C |
| TCMBANKIN060712 | jasmonic acid | C12H18O3 | 210.27 g/mol | CCC=CCC1C(CCC1=O)CC(=O)O | |
| TCMBANKIN061073 | glyceride-1,3-dipalmito-2-sorbate | C41H74O6 | 663 g/mol | CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)C=CC=CC | |
| TCMBANKIN061465 | papaveraldine | xanthaline | C20H19NO5 | 353.37 g/mol | COC1=C(C=C(C=C1)C(=O)C2=NC=CC3=CC(=C(C=C32)OC)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab